Karyopharm Therapeutics Inc. · NASDAQ:KPTI

Abate Kristin sold 378 Karyopharm Therapeutics Inc. shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 2, 2026

On Oct 1, 2026, Abate Kristin (Chief Accounting Officer) sold 378 Karyopharm Therapeutics Inc. shares at US$1.19 for US$450, leaving 23,404 shares. Filed Oct 2, 2026 (Form 4).

Sold
378 shares
Price
US$1.19
Value
US$450
Holding after
23,404 shares
Trading plan
No
Role
Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common StockSale378US$1.1923,404Direct

Source

View original at SEC

Related